935277-36-4

Downstream Products

• 935277-35-3 tert-butyl 1-(3,5-difluorophenyl)-4-(1-(4,4-dimethylpentyl)-cyclopropylamino)-3-hydroxybutan-2-ylcarbamate 
• 935459-83-9 (1-(3,5-difluorobenzyl)-2-hydroxy-3-(1-(3-pyrazol-1-yl-phenyl)-cyclopropylamino)-propyl)-carbamic acid tert-butyl ester 
• 935460-58-5 tert-butyl 4-(1-(3-(2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)phenyl)cyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-ylcarbamate 
• 935460-54-1 tert-butyl 1-(3,5-difluorophenyl)-3-hydroxy-4-(1-(2-neopentylthiazol-4-yl)cyclopropylamino)butan-2-ylcarbamate 
• 935460-49-4 tert-butyl 1-(3,5-difluorophenyl)-3-hydroxy-4-(1-(4-neopentylthiazol-2-yl)cyclopropylamino)butan-2-ylcarbamate 
• 935460-42-7 tert-butyl 4-(1-(3-(1H-pyrazol-1-yl)phenyl)-2-isopropylcyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-ylcarbamate 
• 935460-38-1 tert-butyl 4-(1-(3-(1H-pyrazol-1-yl)phenyl)-2-ethylcyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-ylcarbamate 
• 935460-35-8 tert-butyl 4-(1-(5-tert-butyloxazol-2-yl)cyclopropylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-ylcarbamate 

Relevant academic research and scientific papers

Compounds to treat Alzheimer's disease

The present invention is directed toward substituted hydroxyethylene compounds of formulas (XII) (XIII), and (XIV) useful in treating Alzheimer's disease and other similar diseases.